2.
The Indian pharmaceutical sector is highly
fragmented, with more than 20 000 registered
companies, with the top 250 companies
controlling 70% of the market. These companies
can currently meet about 70% of the countries
demands for drugs; this is mainly through the
Maharashtra and Gujarat regions, which account
for 45% of the total number of pharmaceutical
manufacturing units in India.
3. The Indian pharmaceuticals industry has grown from a
mere $0.3billion in 1980, to $12 billion in 2012.
Branded generics dominate the market, making up 7080% of it.
The price of drugs is very low, due to intense
competition. While India is 10th globally in terms of
value, it is 3rd in term of volume of drugs produced.
4. CURRENT RATIO:
YEAR
2011
2012
2013
CURRENT RATIO
2.43
2.61
1.94
Interpretation : The current ratio of Cipla Ltd is above the
standard norm of 2:1 for the years 2011 and 2012 i.e 2.43
and 2.61. But for the year 2013 it has come down i.e 1.94.
Hence It is adequately liquid from the point of view of its
ability to satisfy the claims of short term creditors.
10. GROSS PROFIT MARGIN
YEAR
2011
2012
2013
Gross profit
margin
17.17
18.8
21.96
Interpretation:
There are high overheads it should be reduced
The processes should be optimized.
Higher values indicate that more cents are earned per dollar of
revenue which is favourable because more profit will be available to
cover non-production costs.
16. INVENTORY TURNOVER RATIO
YEAR
INVENTORY
TURNOVER RATIO
2011
2012
2013
3.7
3.85
3.47
Interpretation:
It is an activity ratio measuring the number of times per period.
The company doesn’t have retained earnings to reinvest it showing constant
fluctuation from year to year.
It has to really work hard to survive in the market.
22. CIPLA LTD
DR REDDY’S LAB
YEAR
2013
2013
CURRENT RATIO
1.94
1.48
QUICK RATIO
1.64
1.6
DEBT EQUITY RATIO
0.11
0.5
GROSS PROFIT MARGIN
22.55
18.33
NET PROFIT MARGIN
18.17
12.74
RETURN ON ASSETS
112.32
375.01
INVENTORY TURNOVER RATIO
3.47
5.51
DEBTORS TURNOVER RATIO
5.14
4.14
ASSET TURNOVER RATIO
0.94
1.33
23. Sources Of Funds
Rs crore
Total Share Capital
160.58
1.63%
Equity Share Capital
160.58
1.63%
Share Application Money
0
0.00%
Preference Share Capital
0
0.00%
8,708.94
88.55%
0
0.00%
8,869.52
90.18%
9.49
0.10%
Unsecured Loans
956.32
9.72%
Total Debt
965.81
9.82%
9,835.33
100.00%
Reserves
Revaluation Reserves
Networth
Secured Loans
Total Liabilities
24. Application Of Funds
Rs crore
Gross Block
4,983.81
50.67%
Less: Accum. Depreciation
1,565.52
15.92%
Net Block
3,418.29
34.76%
350.34
3.56%
Investments
2,601.82
26.45%
Inventories
2,343.37
23.83%
Sundry Debtors
1,645.22
16.73%
105.07
1.07%
Total Current Assets
4,093.66
41.62%
Loans and Advances
1,029.10
10.46%
0
0.00%
5,122.76
52.09%
0
0.00%
1,380.91
14.04%
276.97
2.82%
Total CL & Provisions
1,657.88
16.86%
Net Current Assets
3,464.88
35.23%
0
0.00%
9,835.33
100.00%
Capital Work in Progress
Cash and Bank Balance
Fixed Deposits
Total CA, Loans & Advances
Deffered Credit
Current Liabilities
Provisions
Miscellaneous Expenses
Total Assets